EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Gestational colorectal cancer: Mechanisms, treatments, and prognosis

Xingnan Ge, Yanru Feng, Shisheng Tan, Wei Mao, Yanlin Wang, Ji Zhu iD, Qianping Chen iD

International Journal of Cancer · 2025-08 · 157 (3) · 416-426

DOI: 10.1002/ijc.35425 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Cancer, online erschienen am 03.04.2025. Verfasst von Xingnan Ge und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Pregnancy Complications, Neoplastic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Key Research and Development Program of Zhejiang Province, Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although colorectal cancer (CRC) in pregnancy is extremely rare, occurring in only 0.002% of women during pregnancy, the risk of that is progressively increasing as the incidence of early‐stage CRC rises and the age of pregnancy is delayed. Any indicator of change during pregnancy could be responsible for accelerating the development of cancer. The contradiction between the survival demands of the fetus and maternal energy expenditure makes gestational colorectal cancer (GCRC) not only a medical but also a complex social issue with strong emotional and moral conflicts. This means that physicians, surgeons, radiotherapists, and nutritionists must work closely together to balance the mother and the fetus with the limited treatment experience and data available, and to make win‐win choices regarding the appropriate timing, treatment modality, and dosage of medications. This article briefly discusses the mechanisms, treatment options, and prognosis of CRC during pregnancy in order to provide evidence‐based medicine for the distinct pathogenesis, prevention, diagnosis, and treatment of GCRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsPregnancy Complications, NeoplasticHumansFemalePregnancyPrognosis

Stichwörter der Autor:innen

colorectal cancercytokineestrogenimmunepregnancy

Autor:innen und Institutionen

  • Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China.
  • Postgraduate Training Base Alliance, Wenzhou Medical University, Wenzhou, China.
  • Zhejiang Key Laboratory of Radiation Oncology, Hangzhou, China.
  • Department of Oncology, Guizhou Provincial People's Hospital, Guiyang, China.
  • Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Zhejiang, Hangzhou, China.

ORCID-Profile: Ji Zhu, Qianping Chen

Förderung

  • China Postdoctoral Science Foundation
  • Key Research and Development Program of Zhejiang Province
  • Natural Science Foundation of Zhejiang Province
  • National Natural Science Foundation of China

Zitieren

APA

Ge, X., Feng, Y., Tan, S., Mao, W., Wang, Y., Zhu, J., & Chen, Q. (2025). Gestational colorectal cancer: Mechanisms, treatments, and prognosis. International Journal of Cancer, 157(3), 416-426. https://doi.org/10.1002/ijc.35425

Vancouver

Ge X, Feng Y, Tan S, Mao W, Wang Y, Zhu J, et al. Gestational colorectal cancer: Mechanisms, treatments, and prognosis. International Journal of Cancer. 2025;157(3):416-426. doi:10.1002/ijc.35425

BibTeX
@article{Ge2025,
  author = {Ge, Xingnan and Feng, Yanru and Tan, Shisheng and Mao, Wei and Wang, Yanlin and Zhu, Ji and Chen, Qianping},
  title = {Gestational colorectal cancer: Mechanisms, treatments, and prognosis},
  journal = {International Journal of Cancer},
  year = {2025},
  volume = {157},
  number = {3},
  pages = {416--426},
  doi = {10.1002/ijc.35425}
}
Kostenlos starten →